Ebola and Marburg are among the most deadly viruses, with mortality rates from these infections ranging from 25% to 90%. While no drugs currently are available on the market to prevent infection from these viruses—they ...
Feb 8, 2021
0
77
With Zika virus raising concerns around the United States about the spread of mosquito-borne diseases, the transmission of these viruses has become paramount in terms of how, when and where they are spread. Researchers at ...
Oct 7, 2016
0
3
The world's first dengue vaccine won regulatory approval in Mexico on Wednesday, raising hopes that it could prevent more than 100 deaths there a year and eventually perhaps millions around the world.
Dec 9, 2015
0
11
Researchers at the University of Texas Medical Branch have developed the first accurate predictive model to differentiate between dengue fever (DF) and its more severe form, dengue hemorrhagic fever (DHF). The breakthrough, ...
Feb 16, 2012
0
0
Experimental Ebola vaccines will be deployed in Uganda in about "two weeks," a World Health Organization official said Wednesday, as the East African country carried out tough preventive measures that include a lockdown in ...
Oct 19, 2022
0
0
New research out of the University of Texas Medical Branch potentially points to an effective treatment for Lassa fever, a dangerous, often fatal disease common to much of West Africa but considered a major threat to global ...
Aug 24, 2023
0
22
Japanese pharmaceutical company Takeda said the European Union had given the green light to its dengue fever vaccine, making it the second jab preventing the disease to be approved by the bloc.
Dec 9, 2022
0
13
Remdesivir has been shown to speed up recovery times for patients with COVID-19 in a major US-led trial, becoming the first drug with proven benefit against the disease.
Apr 30, 2020
0
9
In a study published today in the Open Access journal PLOS Pathogens, researchers at Emory University have discovered a potentially important mechanism by which the Ebola virus alters and evades the immune response of its ...
Dec 13, 2012
0
0
Researchers at Karolinska Institutet, in collaboration with JLP Health and others, have identified how the tick-borne Crimean-Congo hemorrhagic fever virus enters our cells. The results are published in Nature Microbiology ...
Mar 28, 2024
0
21
